Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs. Benzathine in Neonates With Possible Congenital Syphilis

NCT07457385 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT07457385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs. Benzathine in Neonates With Possible Congenital Syphilis
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
August 31, 2031
Enrollment
374 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

syphilis, congenital